Cardiac health and management of cardiac disease has been and remains a key focus in our healthcare with more than 50% of all healthcare monies directed toward diagnosis and treatment of cardiac disease. With more and more investment directed toward innovation for disease management, mainstream science is also seeing the emergence of high-end toolkits directed toward early diagnosis and front-end prevention.
We now have the ability to utilize innovative imaging, wearable and laboratory testing technology to screen for early markers of cardiometabolic disease and focus on early detection and pr...
Reader Comments(0)